nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0953	0.134	CbGbCtD
Midazolam—CYP3A7—Ifosfamide—testicular cancer	0.0953	0.134	CbGbCtD
Midazolam—CYP2B6—Ifosfamide—testicular cancer	0.0908	0.128	CbGbCtD
Midazolam—CYP3A5—Ifosfamide—testicular cancer	0.0715	0.101	CbGbCtD
Midazolam—CYP2B6—Cisplatin—testicular cancer	0.0442	0.0623	CbGbCtD
Midazolam—CYP2E1—Etoposide—testicular cancer	0.044	0.062	CbGbCtD
Midazolam—ABCB1—Dactinomycin—testicular cancer	0.0394	0.0556	CbGbCtD
Midazolam—CYP3A5—Etoposide—testicular cancer	0.0342	0.0482	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—testicular cancer	0.0296	0.0417	CbGbCtD
Midazolam—CYP3A4—Ifosfamide—testicular cancer	0.0279	0.0393	CbGbCtD
Midazolam—ABCB1—Vinblastine—testicular cancer	0.0247	0.0348	CbGbCtD
Midazolam—ABCB1—Cisplatin—testicular cancer	0.0226	0.0319	CbGbCtD
Midazolam—ABCB1—Etoposide—testicular cancer	0.0222	0.0314	CbGbCtD
Midazolam—ABCB1—Doxorubicin—testicular cancer	0.0152	0.0214	CbGbCtD
Midazolam—CYP3A4—Vinblastine—testicular cancer	0.0148	0.0209	CbGbCtD
Midazolam—ABCB1—Methotrexate—testicular cancer	0.0147	0.0207	CbGbCtD
Midazolam—CYP3A4—Etoposide—testicular cancer	0.0133	0.0188	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—testicular cancer	0.00909	0.0128	CbGbCtD
Midazolam—Tremor—Cisplatin—testicular cancer	0.000489	0.00168	CcSEcCtD
Midazolam—Lethargy—Methotrexate—testicular cancer	0.000485	0.00167	CcSEcCtD
Midazolam—Nervous system disorder—Ifosfamide—testicular cancer	0.000484	0.00166	CcSEcCtD
Midazolam—Skin disorder—Ifosfamide—testicular cancer	0.00048	0.00165	CcSEcCtD
Midazolam—Phlebitis—Doxorubicin—testicular cancer	0.000478	0.00164	CcSEcCtD
Midazolam—Feeling abnormal—Bleomycin—testicular cancer	0.000476	0.00164	CcSEcCtD
Midazolam—Thrombophlebitis—Doxorubicin—testicular cancer	0.000476	0.00163	CcSEcCtD
Midazolam—Osteoarthritis—Methotrexate—testicular cancer	0.000476	0.00163	CcSEcCtD
Midazolam—Vomiting—Chlorambucil—testicular cancer	0.000475	0.00163	CcSEcCtD
Midazolam—Fatigue—Dactinomycin—testicular cancer	0.000465	0.0016	CcSEcCtD
Midazolam—Hypotension—Ifosfamide—testicular cancer	0.000462	0.00159	CcSEcCtD
Midazolam—Pain—Dactinomycin—testicular cancer	0.000461	0.00158	CcSEcCtD
Midazolam—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00046	0.00158	CcSEcCtD
Midazolam—Urticaria—Bleomycin—testicular cancer	0.000459	0.00158	CcSEcCtD
Midazolam—Cardiac failure—Epirubicin—testicular cancer	0.000456	0.00157	CcSEcCtD
Midazolam—Lethargy—Epirubicin—testicular cancer	0.000454	0.00156	CcSEcCtD
Midazolam—Irritability—Methotrexate—testicular cancer	0.000454	0.00156	CcSEcCtD
Midazolam—Dizziness—Vinblastine—testicular cancer	0.000453	0.00155	CcSEcCtD
Midazolam—Mood swings—Methotrexate—testicular cancer	0.00045	0.00155	CcSEcCtD
Midazolam—Ataxia—Methotrexate—testicular cancer	0.000447	0.00154	CcSEcCtD
Midazolam—Osteoarthritis—Epirubicin—testicular cancer	0.000445	0.00153	CcSEcCtD
Midazolam—Diplopia—Epirubicin—testicular cancer	0.000445	0.00153	CcSEcCtD
Midazolam—Feeling abnormal—Dactinomycin—testicular cancer	0.000444	0.00153	CcSEcCtD
Midazolam—Nausea—Chlorambucil—testicular cancer	0.000444	0.00152	CcSEcCtD
Midazolam—Paraesthesia—Ifosfamide—testicular cancer	0.000444	0.00152	CcSEcCtD
Midazolam—Anxiety—Cisplatin—testicular cancer	0.000443	0.00152	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000441	0.00152	CcSEcCtD
Midazolam—Dyspnoea—Ifosfamide—testicular cancer	0.00044	0.00151	CcSEcCtD
Midazolam—Somnolence—Ifosfamide—testicular cancer	0.000439	0.00151	CcSEcCtD
Midazolam—Affect lability—Epirubicin—testicular cancer	0.000438	0.0015	CcSEcCtD
Midazolam—Vomiting—Vinblastine—testicular cancer	0.000435	0.00149	CcSEcCtD
Midazolam—Vertigo—Etoposide—testicular cancer	0.00043	0.00148	CcSEcCtD
Midazolam—Headache—Vinblastine—testicular cancer	0.000429	0.00147	CcSEcCtD
Midazolam—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000427	0.00146	CcSEcCtD
Midazolam—Fatigue—Ifosfamide—testicular cancer	0.000426	0.00146	CcSEcCtD
Midazolam—Anaphylactic shock—Cisplatin—testicular cancer	0.000426	0.00146	CcSEcCtD
Midazolam—Hypersensitivity—Bleomycin—testicular cancer	0.000426	0.00146	CcSEcCtD
Midazolam—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000425	0.00146	CcSEcCtD
Midazolam—Cardiac arrest—Epirubicin—testicular cancer	0.000423	0.00145	CcSEcCtD
Midazolam—Pain—Ifosfamide—testicular cancer	0.000422	0.00145	CcSEcCtD
Midazolam—Constipation—Ifosfamide—testicular cancer	0.000422	0.00145	CcSEcCtD
Midazolam—Cardiac failure—Doxorubicin—testicular cancer	0.000422	0.00145	CcSEcCtD
Midazolam—Mood swings—Epirubicin—testicular cancer	0.000422	0.00145	CcSEcCtD
Midazolam—Lethargy—Doxorubicin—testicular cancer	0.00042	0.00144	CcSEcCtD
Midazolam—Ataxia—Epirubicin—testicular cancer	0.000418	0.00144	CcSEcCtD
Midazolam—Nervous system disorder—Cisplatin—testicular cancer	0.000418	0.00143	CcSEcCtD
Midazolam—Cough—Etoposide—testicular cancer	0.000417	0.00143	CcSEcCtD
Midazolam—Tachycardia—Cisplatin—testicular cancer	0.000416	0.00143	CcSEcCtD
Midazolam—Asthenia—Bleomycin—testicular cancer	0.000415	0.00142	CcSEcCtD
Midazolam—Skin disorder—Cisplatin—testicular cancer	0.000414	0.00142	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—testicular cancer	0.000412	0.00141	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—testicular cancer	0.000412	0.00141	CcSEcCtD
Midazolam—Pruritus—Bleomycin—testicular cancer	0.000409	0.0014	CcSEcCtD
Midazolam—Feeling abnormal—Ifosfamide—testicular cancer	0.000407	0.0014	CcSEcCtD
Midazolam—Nausea—Vinblastine—testicular cancer	0.000407	0.0014	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—testicular cancer	0.000405	0.00139	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000404	0.00139	CcSEcCtD
Midazolam—Hypotension—Cisplatin—testicular cancer	0.000398	0.00137	CcSEcCtD
Midazolam—Nasopharyngitis—Epirubicin—testicular cancer	0.000398	0.00137	CcSEcCtD
Midazolam—Hypersensitivity—Dactinomycin—testicular cancer	0.000397	0.00136	CcSEcCtD
Midazolam—Confusional state—Etoposide—testicular cancer	0.000393	0.00135	CcSEcCtD
Midazolam—Muscular weakness—Epirubicin—testicular cancer	0.000392	0.00135	CcSEcCtD
Midazolam—Urticaria—Ifosfamide—testicular cancer	0.000392	0.00135	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—testicular cancer	0.000392	0.00134	CcSEcCtD
Midazolam—Anaphylactic shock—Etoposide—testicular cancer	0.00039	0.00134	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—testicular cancer	0.00039	0.00134	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—testicular cancer	0.000387	0.00133	CcSEcCtD
Midazolam—Asthenia—Dactinomycin—testicular cancer	0.000387	0.00133	CcSEcCtD
Midazolam—Paraesthesia—Cisplatin—testicular cancer	0.000382	0.00131	CcSEcCtD
Midazolam—Tachycardia—Etoposide—testicular cancer	0.000381	0.00131	CcSEcCtD
Midazolam—Dyspnoea—Cisplatin—testicular cancer	0.00038	0.0013	CcSEcCtD
Midazolam—Skin disorder—Etoposide—testicular cancer	0.000379	0.0013	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—testicular cancer	0.000368	0.00126	CcSEcCtD
Midazolam—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000368	0.00126	CcSEcCtD
Midazolam—Vomiting—Bleomycin—testicular cancer	0.000368	0.00126	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—testicular cancer	0.000366	0.00126	CcSEcCtD
Midazolam—Depression—Methotrexate—testicular cancer	0.000365	0.00126	CcSEcCtD
Midazolam—Hypotension—Etoposide—testicular cancer	0.000365	0.00125	CcSEcCtD
Midazolam—Rash—Bleomycin—testicular cancer	0.000364	0.00125	CcSEcCtD
Midazolam—Pain—Cisplatin—testicular cancer	0.000364	0.00125	CcSEcCtD
Midazolam—Dermatitis—Bleomycin—testicular cancer	0.000364	0.00125	CcSEcCtD
Midazolam—Hypersensitivity—Ifosfamide—testicular cancer	0.000364	0.00125	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—testicular cancer	0.000363	0.00125	CcSEcCtD
Midazolam—Asthenia—Ifosfamide—testicular cancer	0.000354	0.00122	CcSEcCtD
Midazolam—Feeling abnormal—Cisplatin—testicular cancer	0.000351	0.00121	CcSEcCtD
Midazolam—Paraesthesia—Etoposide—testicular cancer	0.00035	0.0012	CcSEcCtD
Midazolam—Pruritus—Ifosfamide—testicular cancer	0.00035	0.0012	CcSEcCtD
Midazolam—Dyspnoea—Etoposide—testicular cancer	0.000348	0.00119	CcSEcCtD
Midazolam—Somnolence—Etoposide—testicular cancer	0.000347	0.00119	CcSEcCtD
Midazolam—Nausea—Bleomycin—testicular cancer	0.000343	0.00118	CcSEcCtD
Midazolam—Drowsiness—Epirubicin—testicular cancer	0.000343	0.00118	CcSEcCtD
Midazolam—Vomiting—Dactinomycin—testicular cancer	0.000343	0.00118	CcSEcCtD
Midazolam—Rash—Dactinomycin—testicular cancer	0.00034	0.00117	CcSEcCtD
Midazolam—Gastrointestinal disorder—Etoposide—testicular cancer	0.000337	0.00116	CcSEcCtD
Midazolam—Fatigue—Etoposide—testicular cancer	0.000336	0.00116	CcSEcCtD
Midazolam—Neuropathy peripheral—Epirubicin—testicular cancer	0.000336	0.00115	CcSEcCtD
Midazolam—Constipation—Etoposide—testicular cancer	0.000334	0.00115	CcSEcCtD
Midazolam—Pain—Etoposide—testicular cancer	0.000334	0.00115	CcSEcCtD
Midazolam—Dizziness—Ifosfamide—testicular cancer	0.000327	0.00112	CcSEcCtD
Midazolam—Feeling abnormal—Etoposide—testicular cancer	0.000322	0.0011	CcSEcCtD
Midazolam—Nausea—Dactinomycin—testicular cancer	0.00032	0.0011	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—testicular cancer	0.000317	0.00109	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—testicular cancer	0.000317	0.00109	CcSEcCtD
Midazolam—Vomiting—Ifosfamide—testicular cancer	0.000314	0.00108	CcSEcCtD
Midazolam—Hypersensitivity—Cisplatin—testicular cancer	0.000314	0.00108	CcSEcCtD
Midazolam—Bradycardia—Epirubicin—testicular cancer	0.000313	0.00108	CcSEcCtD
Midazolam—Rash—Ifosfamide—testicular cancer	0.000311	0.00107	CcSEcCtD
Midazolam—Dermatitis—Ifosfamide—testicular cancer	0.000311	0.00107	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000311	0.00107	CcSEcCtD
Midazolam—Urticaria—Etoposide—testicular cancer	0.00031	0.00106	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—testicular cancer	0.000307	0.00106	CcSEcCtD
Midazolam—Asthenia—Cisplatin—testicular cancer	0.000306	0.00105	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—testicular cancer	0.000305	0.00105	CcSEcCtD
Midazolam—Connective tissue disorder—Epirubicin—testicular cancer	0.000303	0.00104	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—testicular cancer	0.000297	0.00102	CcSEcCtD
Midazolam—Visual impairment—Epirubicin—testicular cancer	0.000297	0.00102	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—testicular cancer	0.000296	0.00102	CcSEcCtD
Midazolam—Chills—Methotrexate—testicular cancer	0.000295	0.00101	CcSEcCtD
Midazolam—Nausea—Ifosfamide—testicular cancer	0.000293	0.00101	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—testicular cancer	0.00029	0.000996	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—testicular cancer	0.000288	0.00099	CcSEcCtD
Midazolam—Eye disorder—Epirubicin—testicular cancer	0.000288	0.000988	CcSEcCtD
Midazolam—Hypersensitivity—Etoposide—testicular cancer	0.000287	0.000987	CcSEcCtD
Midazolam—Erythema—Methotrexate—testicular cancer	0.000286	0.000984	CcSEcCtD
Midazolam—Cardiac disorder—Epirubicin—testicular cancer	0.000286	0.000981	CcSEcCtD
Midazolam—Asthenia—Etoposide—testicular cancer	0.00028	0.000962	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—testicular cancer	0.00028	0.000961	CcSEcCtD
Midazolam—Immune system disorder—Epirubicin—testicular cancer	0.000278	0.000955	CcSEcCtD
Midazolam—Mediastinal disorder—Epirubicin—testicular cancer	0.000277	0.000953	CcSEcCtD
Midazolam—Chills—Epirubicin—testicular cancer	0.000276	0.000949	CcSEcCtD
Midazolam—Pruritus—Etoposide—testicular cancer	0.000276	0.000948	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—testicular cancer	0.000275	0.000943	CcSEcCtD
Midazolam—Vomiting—Cisplatin—testicular cancer	0.000271	0.00093	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—testicular cancer	0.00027	0.000927	CcSEcCtD
Midazolam—Mental disorder—Epirubicin—testicular cancer	0.00027	0.000926	CcSEcCtD
Midazolam—Rash—Cisplatin—testicular cancer	0.000269	0.000922	CcSEcCtD
Midazolam—Dermatitis—Cisplatin—testicular cancer	0.000268	0.000922	CcSEcCtD
Midazolam—Erythema—Epirubicin—testicular cancer	0.000268	0.00092	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—testicular cancer	0.000266	0.000914	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—testicular cancer	0.000264	0.000908	CcSEcCtD
Midazolam—Tension—Epirubicin—testicular cancer	0.000263	0.000903	CcSEcCtD
Midazolam—Nervousness—Epirubicin—testicular cancer	0.00026	0.000894	CcSEcCtD
Midazolam—Dizziness—Etoposide—testicular cancer	0.000258	0.000886	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—testicular cancer	0.000257	0.000884	CcSEcCtD
Midazolam—Vertigo—Methotrexate—testicular cancer	0.000257	0.000884	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—testicular cancer	0.000257	0.000882	CcSEcCtD
Midazolam—Chills—Doxorubicin—testicular cancer	0.000256	0.000878	CcSEcCtD
Midazolam—Nausea—Cisplatin—testicular cancer	0.000253	0.000869	CcSEcCtD
Midazolam—Vision blurred—Epirubicin—testicular cancer	0.000253	0.000867	CcSEcCtD
Midazolam—Cough—Methotrexate—testicular cancer	0.00025	0.000858	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—testicular cancer	0.00025	0.000857	CcSEcCtD
Midazolam—Vomiting—Etoposide—testicular cancer	0.000248	0.000852	CcSEcCtD
Midazolam—Erythema—Doxorubicin—testicular cancer	0.000248	0.000852	CcSEcCtD
Midazolam—Agitation—Epirubicin—testicular cancer	0.000246	0.000846	CcSEcCtD
Midazolam—Rash—Etoposide—testicular cancer	0.000246	0.000845	CcSEcCtD
Midazolam—Dermatitis—Etoposide—testicular cancer	0.000246	0.000844	CcSEcCtD
Midazolam—Headache—Etoposide—testicular cancer	0.000244	0.00084	CcSEcCtD
Midazolam—Tension—Doxorubicin—testicular cancer	0.000243	0.000836	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000242	0.000832	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—testicular cancer	0.000241	0.000827	CcSEcCtD
Midazolam—Vertigo—Epirubicin—testicular cancer	0.000241	0.000827	CcSEcCtD
Midazolam—Syncope—Epirubicin—testicular cancer	0.00024	0.000825	CcSEcCtD
Midazolam—Confusional state—Methotrexate—testicular cancer	0.000236	0.000809	CcSEcCtD
Midazolam—Cough—Epirubicin—testicular cancer	0.000234	0.000803	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—testicular cancer	0.000234	0.000803	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—testicular cancer	0.000234	0.000803	CcSEcCtD
Midazolam—Nausea—Etoposide—testicular cancer	0.000232	0.000796	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—testicular cancer	0.000229	0.000787	CcSEcCtD
Midazolam—Agitation—Doxorubicin—testicular cancer	0.000228	0.000783	CcSEcCtD
Midazolam—Anxiety—Epirubicin—testicular cancer	0.000227	0.000781	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—testicular cancer	0.000227	0.00078	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000227	0.000778	CcSEcCtD
Midazolam—Dry mouth—Epirubicin—testicular cancer	0.000223	0.000766	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—testicular cancer	0.000223	0.000765	CcSEcCtD
Midazolam—Syncope—Doxorubicin—testicular cancer	0.000222	0.000764	CcSEcCtD
Midazolam—Confusional state—Epirubicin—testicular cancer	0.000221	0.000757	CcSEcCtD
Midazolam—Anaphylactic shock—Epirubicin—testicular cancer	0.000219	0.000751	CcSEcCtD
Midazolam—Hypotension—Methotrexate—testicular cancer	0.000218	0.00075	CcSEcCtD
Midazolam—Cough—Doxorubicin—testicular cancer	0.000216	0.000743	CcSEcCtD
Midazolam—Shock—Epirubicin—testicular cancer	0.000215	0.000739	CcSEcCtD
Midazolam—Nervous system disorder—Epirubicin—testicular cancer	0.000214	0.000737	CcSEcCtD
Midazolam—Tachycardia—Epirubicin—testicular cancer	0.000213	0.000733	CcSEcCtD
Midazolam—Skin disorder—Epirubicin—testicular cancer	0.000212	0.00073	CcSEcCtD
Midazolam—Anxiety—Doxorubicin—testicular cancer	0.00021	0.000723	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—testicular cancer	0.00021	0.000721	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00021	0.00072	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—testicular cancer	0.000208	0.000716	CcSEcCtD
Midazolam—Somnolence—Methotrexate—testicular cancer	0.000208	0.000714	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—testicular cancer	0.000206	0.000709	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—testicular cancer	0.000206	0.000707	CcSEcCtD
Midazolam—Hypotension—Epirubicin—testicular cancer	0.000204	0.000702	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—testicular cancer	0.000204	0.000701	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—testicular cancer	0.000202	0.000695	CcSEcCtD
Midazolam—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000202	0.000693	CcSEcCtD
Midazolam—Fatigue—Methotrexate—testicular cancer	0.000202	0.000692	CcSEcCtD
Midazolam—Pain—Methotrexate—testicular cancer	0.0002	0.000686	CcSEcCtD
Midazolam—Shock—Doxorubicin—testicular cancer	0.000199	0.000684	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—testicular cancer	0.000198	0.000682	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—testicular cancer	0.000198	0.000678	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—testicular cancer	0.000197	0.000675	CcSEcCtD
Midazolam—Paraesthesia—Epirubicin—testicular cancer	0.000196	0.000675	CcSEcCtD
Midazolam—Dyspnoea—Epirubicin—testicular cancer	0.000195	0.00067	CcSEcCtD
Midazolam—Somnolence—Epirubicin—testicular cancer	0.000194	0.000668	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—testicular cancer	0.000193	0.000662	CcSEcCtD
Midazolam—Dyspepsia—Epirubicin—testicular cancer	0.000193	0.000661	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—testicular cancer	0.000189	0.00065	CcSEcCtD
Midazolam—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000189	0.000649	CcSEcCtD
Midazolam—Fatigue—Epirubicin—testicular cancer	0.000189	0.000648	CcSEcCtD
Midazolam—Pain—Epirubicin—testicular cancer	0.000187	0.000642	CcSEcCtD
Midazolam—Constipation—Epirubicin—testicular cancer	0.000187	0.000642	CcSEcCtD
Midazolam—Urticaria—Methotrexate—testicular cancer	0.000186	0.000638	CcSEcCtD
Midazolam—Paraesthesia—Doxorubicin—testicular cancer	0.000182	0.000624	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—testicular cancer	0.00018	0.00062	CcSEcCtD
Midazolam—Feeling abnormal—Epirubicin—testicular cancer	0.00018	0.000619	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—testicular cancer	0.00018	0.000618	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—testicular cancer	0.000178	0.000612	CcSEcCtD
Midazolam—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000175	0.0006	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—testicular cancer	0.000174	0.000599	CcSEcCtD
Midazolam—Urticaria—Epirubicin—testicular cancer	0.000174	0.000597	CcSEcCtD
Midazolam—Pain—Doxorubicin—testicular cancer	0.000173	0.000594	CcSEcCtD
Midazolam—Constipation—Doxorubicin—testicular cancer	0.000173	0.000594	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—testicular cancer	0.000172	0.000591	CcSEcCtD
Midazolam—Asthenia—Methotrexate—testicular cancer	0.000168	0.000576	CcSEcCtD
Midazolam—Feeling abnormal—Doxorubicin—testicular cancer	0.000167	0.000573	CcSEcCtD
Midazolam—Pruritus—Methotrexate—testicular cancer	0.000165	0.000568	CcSEcCtD
Midazolam—Hypersensitivity—Epirubicin—testicular cancer	0.000161	0.000553	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—testicular cancer	0.000161	0.000552	CcSEcCtD
Midazolam—Asthenia—Epirubicin—testicular cancer	0.000157	0.000539	CcSEcCtD
Midazolam—Pruritus—Epirubicin—testicular cancer	0.000155	0.000532	CcSEcCtD
Midazolam—Dizziness—Methotrexate—testicular cancer	0.000155	0.000531	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—testicular cancer	0.000149	0.000512	CcSEcCtD
Midazolam—Vomiting—Methotrexate—testicular cancer	0.000149	0.00051	CcSEcCtD
Midazolam—Rash—Methotrexate—testicular cancer	0.000147	0.000506	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—testicular cancer	0.000147	0.000506	CcSEcCtD
Midazolam—Headache—Methotrexate—testicular cancer	0.000146	0.000503	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—testicular cancer	0.000145	0.000499	CcSEcCtD
Midazolam—Dizziness—Epirubicin—testicular cancer	0.000145	0.000497	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—testicular cancer	0.000143	0.000492	CcSEcCtD
Midazolam—Vomiting—Epirubicin—testicular cancer	0.000139	0.000478	CcSEcCtD
Midazolam—Nausea—Methotrexate—testicular cancer	0.000139	0.000477	CcSEcCtD
Midazolam—Rash—Epirubicin—testicular cancer	0.000138	0.000474	CcSEcCtD
Midazolam—Dermatitis—Epirubicin—testicular cancer	0.000138	0.000473	CcSEcCtD
Midazolam—Headache—Epirubicin—testicular cancer	0.000137	0.000471	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—testicular cancer	0.000134	0.00046	CcSEcCtD
Midazolam—Nausea—Epirubicin—testicular cancer	0.00013	0.000446	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—testicular cancer	0.000129	0.000442	CcSEcCtD
Midazolam—Rash—Doxorubicin—testicular cancer	0.000128	0.000438	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—testicular cancer	0.000127	0.000438	CcSEcCtD
Midazolam—Headache—Doxorubicin—testicular cancer	0.000127	0.000435	CcSEcCtD
Midazolam—Nausea—Doxorubicin—testicular cancer	0.00012	0.000413	CcSEcCtD
